BeStock  
Stocks › Biotechnology › MAZE

Maze Therapeutics MAZE

US equityMarket cap rank #2785Biotechnology
$31.37 −$1.06 (-3.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $31.37 0.00%
Open$31.77
Prev close$32.43
Day range$30.88 – $32.80
Volume818.9K
Market cap$1.72B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$51.52M-56.3% YoY
Net profit-$47.97M-59.4% YoY
Diluted EPS-$0.79-19.7% YoY
Free cash flow-$33.13M-34.1% YoY
Operating cash flow-$32.84M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$20.0MMar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-29.6MDec '24$-32.8MMar '25$-33.7MJun '25$-30.1MSep '25$-34.6MDec '25$-24.2MMar '26$-44.7MJun '26$-48.0MSep '26

Diluted EPS by quarter

-1.02Dec '24-1.15Mar '25-0.77Jun '25-0.66Sep '25-0.65Dec '25-0.45Mar '26-0.76Jun '26-0.79Sep '26

Free cash flow by quarter

$-23.1MDec '24$-29.8MMar '25$-30.4MJun '25$-24.7MSep '25$-27.8MDec '25$-39.2MMar '26$-15.2MJun '26$-33.1MSep '26

Annual revenue

$0.0FY22$0.0FY23$167.5MFY24$0.0FY25

Profitability & balance sheet

Operating margin-820.8%
Net margin-757.4%
Return on equity-37.5%
Return on assets-32.4%
Return on invested capital-37.4%
Current ratio14.14
Liabilities / assets16.2%
Cash & investments$389.66M
Total debt$54.71M
Net cash (debt)$334.95M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $20.00M $0.00 $0.00
Total Operating Revenue $0.00 $0.00 $20.00M $0.00 $0.00
Operating Expense $51.52M $48.04M $46.55M $142.90M $38.06M
Selling and Admin Expenses $11.30M $13.10M $12.41M $34.45M $10.49M
-General & Admin Expense $11.30M $13.10M $12.41M $34.45M $10.49M
Research & Development $40.22M $34.94M $34.15M $108.45M $27.57M
Operating Profit -$51.52M -$48.04M -$26.55M -$142.90M -$38.06M
Net Non-Operating Interest Income (Expense) $3.55M $3.31M $2.35M $11.78M $3.49M
Non-Operating Interest Income $4.52M $4.24M $3.21M $11.78M $3.49M
Non-Operating Interest Expense $975,000.00 $931,000.00 $866,000.00 – –
Pretax Profit -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Net Profit -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Profit from Continuing Operations -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Net Income to Parent Company -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Net Income to Common Stockholders -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Basic EPS -$0.79 -$0.76 -$0.45 -$3.05 -$0.65
Diluted EPS -$0.79 -$0.76 -$0.45 -$3.05 -$0.65
Tax – – – $0.00 $0.00
Other Preferred Stock Dividends – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $511.56M $531.63M $419.71M $397.13M $397.13M
Total Current Assets $400.10M $420.42M $379.78M $349.72M $349.72M
Cash and Cash Equivalents & Short-Term Investments $389.66M $411.09M $352.38M $341.92M $341.92M
-Cash and Cash Equivalents $154.16M $202.64M $198.77M $189.25M $189.25M
-Short Term Investments $235.50M $208.44M $153.62M $152.67M $152.67M
Other Current Assets $10.44M $9.34M $7.40M $7.80M $7.80M
Total Non-Current Assets $111.46M $111.20M $39.93M $47.41M $47.41M
Net PPE $21.94M $22.83M $23.97M $25.16M $25.16M
-Gross PPE $21.94M $22.83M $23.97M $44.37M $44.37M
Investments and Advances $87.32M $83.82M $10.56M $18.11M $18.11M
-Available for Sale Securities $87.32M $83.82M $10.56M $18.11M $18.11M
Other Non-Current Assets $2.19M $4.55M $5.41M $4.14M $4.14M
Total Liabilities $83.01M $78.50M $78.01M $42.16M $42.16M
Total Current Liabilities $28.30M $22.96M $21.24M $22.56M $22.56M
Payables $4.57M $2.21M $4.01M $1.79M $1.79M
-Accounts Payable $4.57M $2.21M $4.01M $1.79M $1.79M
Current Accrued Expenses $9.06M $8.94M $6.97M $5.11M $5.11M
Short-Term Debt and Capital Lease Obligation $4.93M $4.88M $4.84M $4.80M $4.80M
-Current Capital Lease Obligation $4.93M $4.88M $4.84M $4.80M $4.80M
Total Non-Current Liabilities $54.71M $55.54M $56.77M $19.61M $19.61M
Long Term Debt and Capital Lease Obligation $54.71M $55.54M $56.39M $18.51M $18.51M
-Long Term Debt $39.12M $38.96M $38.83M – –
-Long Term Capital Lease Obligation $15.59M $16.58M $17.55M $18.51M $18.51M
Total Equity $428.55M $453.12M $341.70M $354.97M $354.97M
Stockholders' Equity $428.55M $453.12M $341.70M $354.97M $354.97M
Capital Stock $56,000.00 $56,000.00 $50,000.00 $49,000.00 $49,000.00
-Common Stock $56,000.00 $56,000.00 $50,000.00 $49,000.00 $49,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.04B $1.01B $855.54M $844.35M $844.35M
Retained Earnings -$606.45M -$558.48M -$513.76M -$489.55M -$489.55M
Gains/Losses Not Affecting Retained Earnings -$1.14M -$435,000.00 -$135,000.00 $110,000.00 $110,000.00
Receivables – – $20.00M – –
-Accounts Receivable – – $20.00M – –
Other Non-Current Liabilities – – $388,000.00 $1.09M $1.09M
-Accumulated Depreciation – – – -$19.21M -$19.21M
Convertible preferred securities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$32.84M -$15.05M -$39.11M -$111.94M -$27.73M
Net cash flow from continuing operations -$32.84M -$15.05M -$39.11M -$111.94M -$27.73M
Net Income from Continuing Operations -$47.97M -$44.73M -$24.21M -$131.12M -$34.57M
Depreciation & Depletion & Amortization $385,000.00 $391,000.00 $444,000.00 $2.40M $499,000.00
Other Non-Cash Items $878,000.00 $972,000.00 $1.22M $2.65M $577,000.00
Change in Working Capital $5.33M $19.12M -$23.68M -$2.27M -$311,000.00
-Change in Prepaid Assets $1.05M -$1.94M $404,000.00 -$2.94M -$433,000.00
-Change in Payables and Accrued Expense $5.02M $2.18M -$1.85M $3.46M $838,000.00
-Change in Other Current Assets $199,000.00 $193,000.00 -$605,000.00 $537,000.00 $163,000.00
-Change in Other Current Liabilities -$941,000.00 -$1.32M -$1.62M -$3.32M -$879,000.00
Net cash flow from investing -$31.41M -$128.51M $6.28M -$170.96M -$103.39M
Net Cash Flow from Continuing Investing Activities -$31.41M -$128.51M $6.28M -$170.96M -$103.39M
Net PPE Purchase and Sale -$288,000.00 -$107,000.00 -$93,000.00 -$794,000.00 -$34,000.00
Net Investment Purchase and Sale -$31.12M -$128.40M $6.37M -$170.17M -$103.35M
Financing Cash Flow $15.77M $147.44M $42.36M $275.34M $3.59M
Net Cash Flow from Continuing Financing Activities $15.77M $147.44M $42.36M $275.34M $3.59M
Net Issuance Payments Of Debt $0.00 $0.00 $39.40M $0.00 $0.00
Net Common Stock Issuance $0.00 $146.66M $0.00 $270.28M -$2.29M
Proceeds from Stock Option Exercised $1.17M $1.70M $4.08M $5.56M $3.43M
Net Other Financing Charges $14.60M -$917,000.00 -$1.12M -$500,000.00 $2.45M
Ending Cash Balance $155.24M $203.73M $199.85M $190.34M $190.34M
Net Change in Cash -$48.49M $3.88M $9.52M -$7.57M -$127.53M
Beginning Cash Balance $203.73M $199.85M $190.34M $197.90M $317.86M
Free Cash Flow -$33.13M -$15.16M -$39.21M -$112.73M -$27.76M
-Change in Receivables – – -$20.00M – –
Net Preferred Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on MAZE.

Sign in to join the discussion.

Scroll to Top